Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2023-04-25 Declaration of Voting R…
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Book Closure
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a short notice dated April 25, 2023, addressed to stock exchanges regarding the book closure and record date for the Annual General Meeting (AGM) and dividend declaration. It references SEBI regulation 42 about disclosure requirements. The content is an announcement about the timing of the AGM and dividend record date, not the AGM materials themselves or the dividend details. The document length is only 1742 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Notice of Dividend Amount (DIV). However, since it primarily informs about book closure and record date for AGM and dividend, it aligns best with DVA, which covers official results and announcements related to shareholder meetings. The document does not contain voting results but is closely related to the AGM process and shareholder rights announcements. Given the options, DVA is the most appropriate classification for this type of regulatory announcement about shareholder meeting logistics and record dates.
2023-04-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the audio transcript of a conference call held on April 24, 2023. It references an earnings call dated April 19, 2023, and provides a link to the audio recording of the call. The content is an announcement for record purposes and does not contain the transcript text itself or financial data. The document length is short (1395 characters), and it serves as a notification about the availability of the call recording rather than the call transcript itself. According to the classification rules, such a document is best classified as a Call Transcript (CT) because it relates directly to the earnings call transcript/audio, even though it is an announcement of the transcript/audio availability. The closest and most appropriate category is CT, as it pertains to conference call content.
2023-04-25 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the year ended 31st March 2023, submitted pursuant to SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on related party transactions, including loans, advances, purchases, and salaries, with specific values and balances. The document is 8073 characters long, which is substantial and contains actual financial data rather than just an announcement or certification. This type of disclosure is typically part of regulatory filings but given the detailed financial data and the nature of the content focusing on related party transactions, it fits best under Regulatory Filings (RNS) as it does not constitute a full annual report, audit report, or interim report. It is a compliance disclosure required by SEBI regulations, which is a common type of regulatory filing.
2023-04-25 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation titled 'Q4 & FY23 Investor Presentation' dated April 22, 2023, covering unaudited financial results for the fiscal year ended March 31, 2023. It includes extensive financial data such as income statements, segmental revenue, operating performance, historical income statements, and balance sheets. The content is structured as a presentation with strategy, product information, leadership team, and financial highlights. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The presence of forward-looking statements and detailed financial metrics aligns with an investor presentation rather than an earnings release or annual report. Therefore, the document fits the category of an Investor Presentation (IP).
2023-04-22 English
Outcome of Board Meeting
Regulatory Filings
2023-04-22 English
Dividend
Regulatory Filings
2023-04-22 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.